# GAIN THERAPEUTICS INC (GANX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/GANX/

- Reporting holders: 1
- Reported value: $23.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [BENEDICT FINANCIAL ADVISORS INC](https://holderbook.com/funds/711089-benedict-financial-advisors-inc/) | $23.4K | 13,500 | 0.0% | 8 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $23.4K |
| Q2 2026 | 51 | $19.6M |
| Q1 2026 | 41 | $16.4M |
| Q4 2025 | 49 | $26.5M |
| Q3 2025 | 39 | $7.9M |
| Q2 2025 | 34 | $6.6M |
| Q1 2025 | 33 | $5.1M |
| Q4 2024 | 26 | $4.0M |
| Q3 2024 | 19 | $2.4M |
| Q2 2024 | 27 | $3.9M |
| Q1 2024 | 26 | $7.2M |
| Q4 2023 | 25 | $5.1M |